What innovative business models can be triggered by precision medicine? Analogical reasoning from the magazine industry

References

• National Institutes of Health. Precision Medicine Initiative. 2015. Available from: http://www.nih.gov/precisionmedicine. Accessed July 27, 2015.
   Google Scholar
• Baldock AL, Rockne RC, Boone AD, et al. From patient-specific mathematical neuro-oncology to precision medicine. Front Oncol. 2013;3:62.
   Google Scholar
• Faulkner E, Annemans L, Garrison L, et al. Challenges in the development and reimbursement of personalized medicine – payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group. Value Health. 2012;15(8):1162–1171.
   PubMed Web of Science ®Google Scholar
• Martins LL, Rindova VP, Greenbaum BE. Unlocking the hidden value of concepts: a cognitive approach to business model innovation. Strateg Entrep J. 2015;9(1):99–117.
   Web of Science ®Google Scholar
• Yap TA, Popat S. Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer. Pharmacogenomics Pers Med. 2014;7:285–295.
   PubMedGoogle Scholar
• Pasche B, Grant SC. Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. JAMA. 2014;311(19):1975–1976.
   PubMed Web of Science ®Google Scholar
• Seiwert T. Accurate HPV testing: a requirement for precision medicine for head and neck cancer. Ann Oncol. 2013;24(11):2711–2713.
   Web of Science ®Google Scholar
• White House. Fact sheet: President Obama’s Precision Medicine Initiative [press release. Washington: White House; [January 30, 2015]. Available from: https://www.whitehouse.gov/the-press-office/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative. Accessed July 28, 2015.
   Google Scholar
• Tufts Center for the Study of Drug Development. Cost to develop and win marketing approval for a new drug is $2.6 billion. 2014. Available from: http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study. Accessed July 28, 2015.
   Google Scholar
• Relman AS, Angell M. America’s other drug problem: how the drug industry distorts medicine and politics. New Repub. 2002(25):27–41.
   Google Scholar
• Ntai A, Baronchelli S, Pellegrino T, De Blasio P, Biunno I. Biobanking shifts to “precision medicine”. J Biorepository Sci Appl Med. 2014;2:11–15.
   Google Scholar
• Hsu W, Markey MK, Wang MD. Biomedical imaging informatics in the era of precision medicine: progress, challenges, and opportunities. J Am Med Inform Assoc. 2013;20(6):1010–1013.
   Web of Science ®Google Scholar
• Rubin MA. Health: make precision medicine work for cancer care. Nature. 2015;520(7547):290–291.
   PubMed Web of Science ®Google Scholar
• Chen R, Snyder M. Promise of personalized omics to precision medicine. Wiley Interdiscip Rev Syst Biol Med. 2013;5(1):73–82.
   PubMed Web of Science ®Google Scholar
• Roijakkers N, Hagedoorn J. Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: trends, patterns, and networks. Res Policy. 2006;35(3):431–446.
   Web of Science ®Google Scholar
• Powell WW. Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries. Calif Manage Rev. 1998;40(3):228–240.
   Web of Science ®Google Scholar
• Sabatier V, Craig-Kennard A, Mangematin V. When technological discontinuities and disruptive business models challenge dominant industry logics: insights from the drugs industry. Technol Forecast Soc Change. 2012;79(5):949–962.
   Web of Science ®Google Scholar
• Baden-Fuller C, Haefliger S. Business models and technological innovation. Long Range Plann. 2013;46(6):419–426.
   Web of Science ®Google Scholar
• Chesbrough H. Business model innovation: opportunities and barriers. Long Range Plann. 2010;43(2–3):354–363.
   Web of Science ®Google Scholar
• Teece DJ. Business models, business strategy and innovation. Long Range Plann. 2010;43(2–3):172–194.
   Web of Science ®Google Scholar
• Chesbrough, H. Business model innovation: it’s not just about technology anymore. Strategy Leadersh. 2007;35(6):12–17.
   Google Scholar
• Baden-Fuller C, Mangematin V. Business models: a challenging agenda. Strateg Organ. 2013;11(4):418–427.
   Web of Science ®Google Scholar
• Hienerth C, Keinz P, Lettl C. Exploring the nature and implementation process of user-centric business models. Long Range Plann. 2011;44(5–6):344–374.
   Web of Science ®Google Scholar
• Agarwal R, Tripsas M. . Technology and industry evolution. In: Shane S, editor. Handbook of Technology and Innovation Management. Bognor Regis, UK: Wiley & Sons; 2008:3–55.
   Google Scholar
• Klepper S. Industry life cycles. Ind Corp Change.1997;6(1):145–181.
   Google Scholar
• Klepper S, Graddy E. The evolution of new industries and determinants of market structure. Rand J Econ.1990;21(1):27–44.
   Google Scholar
• Klepper S, Simons KL. Industry shakeouts and technological change. Int J Ind Organ. 2005;23(1–2):23–43.
   Web of Science ®Google Scholar
• Afuah AN, Utterback JM. Responding to structural industry changes: a technological evolution perspective. Ind Corp Change. 1997;6(1):183–202.
   Google Scholar
• Phaal R, O’Sullivan E, Routley M, Ford S, Probert DA. Framework for mapping industrial emergence. Technol Forecast Soc Change. 2011;78(2):217–230.
   Web of Science ®Google Scholar
• Gilbert C. Unbundling the structure of inertia: resource versus routine rigidity. Acad Manage J. 1995;48(5):741–763.
   Google Scholar
• Gambardella A, McGahan AM. Business-model innovation: general purpose technologies and their implications for industry structure. Long Range Plann. 2010;43(2–3):262–271.
   Web of Science ®Google Scholar
• Agarwal R, Bayus BL. The market evolution and sales takeoff of product innovations. Manag Sci. 2002;48(8):1024–1041.
   Web of Science ®Google Scholar
• Tripsas M, Gavetti G. Capabilities, cognition, and inertia: evidence from digital imaging. Strateg Manag J. 2000;21(10–11):1147–1161.
   Web of Science ®Google Scholar
• Sabatier V, Mangematin V, Rousselle T. From recipe to dinner: business model portfolios in the European biopharmaceutical industry. Long Range Plann. 2010;43(2–3):431–447.
   Web of Science ®Google Scholar
• Murray JR. The first $4 billion is the hardest. Biotechnology (N Y). 1986;4:293–296.
   Google Scholar
• Baum JA, Silverman BS. Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups. J Bus Ventur. 2004;19(3):411–436.
   Web of Science ®Google Scholar
• Howells J, Gagliardi D, Malik K. The growth and management of R&D outsourcing: evidence from UK pharmaceuticals. RD Manag. 2008;38(2):205–219.
   Google Scholar
• Pisano G, Shan W, Teece DJ. . Joint ventures and collaboration in biotechnology. In: Mowery D, editor. International Collaborative Ventures in US Manufacturing. Cambridge (MA): Ballinger; 1988:183–222.
   Google Scholar
• Powell WW, Koput KW, Smith-Doerr L. Interorganizational collaboration and the locus of innovation. Networks of learning in biotechnology. Adm Sci Q. 1966;41(1):116–145.
   Google Scholar
• Rothaermel FT. Complementary assets, strategic alliances, and the incumbent’s advantage: an empirical study of industry and firm effects in the biopharmaceutical industry. Res Policy. 2001;30(8):1235–1251.
   Web of Science ®Google Scholar
• Hopkins MM, Martin PA, Nightingale P, Kraft A, Mahdi S. The myth of biotech revolution: an assessment of technological, clinical and organisational change. Res Policy. 2007;36(4):566–589.
   Web of Science ®Google Scholar
• Eisenhardt K. Building theories from case study research. Acad Manage Rev. 1989;14(4):532–550.
   Web of Science ®Google Scholar
• Eisenhardt KM, Graebner ME. Theory building from cases: opportunities and challenges. Acad Manage J. 2007;50(1):25–32.
   Web of Science ®Google Scholar
• Santos F, Eisenhardt KM. Constructing markets and shaping boundaries: entrepreneurial power in nascent fields. Acad Manage J. 2009;52(4):643–671.
   Web of Science ®Google Scholar
• Yin RK. Case Study Research: Design and Methods. 2nd ed. Beverly Hills (CA): Sage Publications; 1984.
   Google Scholar
• Yin RK. Case Study Research: Design and Methods. 3rd ed. Thousand Oaks (CA): Sage Publications; 2003.
   Google Scholar
• Patton MQ. Qualitative Research and Evaluation Methods. 3rd ed. Thousand Oaks (CA): Sage Publications; 2001.
   Google Scholar
• Morrish J, Bradshaw P. Magazine Editing in Print and Online. Abingdon, UK: Routledge; 2012.
   Google Scholar
• Groupe Xerfi. Pharmaceutical groups – world. 2014. Available from: http://www.xerfi.com/presentationetude/Pharmaceuticals-Groups-World_4XCHE01. Accessed July 28, 2015.
   Google Scholar
• Groupe Xerfi. World media companies. Xerfi Global. 2014. Available from: http://www.xerfi.com/presentationetude/World-Media-Companies_4XCOM01. Accessed July 28, 2015.
   Google Scholar
• PricewaterhouseCoopers LLP. Game Changer: A New Kind of Value Chain for Entertainment and Media Companies. London: PwC; 2013. Available from: http://www.pwc.com/en_US/us/industry/entertainment-media/publications/assets/pwc-value-chain.pdf. Accessed July 28, 2015.
   Google Scholar
• Kaiser U, Wright J. Price structure in two-sided markets: evidence from the magazine industry. Int J Ind Organ. 2006;24(1):1–28.
   Web of Science ®Google Scholar
• Guenther M. Magazine publishing in transition: unique challenges for multi-media platforms. Publ Res Q. 2011;27(4):327–331.
   Google Scholar
• Hearst Magazines International [website on the Internet]. Available from: https://www.hearst.com/magazines/hearst-magazines-international. Accessed July 28, 2015.
   Google Scholar
• Swartz SR. A New Year’s letter from Hearst President and CEO Steven R. Swartz. 2015. Available from: https://www.hearst.com/newsroom/a-new-year-s-letter-from-hearst-ceo-steven-r-swartz-2015. Accessed July 28, 2015.
   Google Scholar
• Edwards D. Building a global print business, while pivoting to a digital future. Poster presented at the 39th FIPP Congress; September 2013; Rome.
   Google Scholar
• Hearst Communications. Leveraging data. 2015. Available from: http://www.hearst.com/newsroom/leveraging-data. Accessed July 28, 2015.
   Google Scholar
• Hearst Digital Media. Q&A with Mike Smith. 2013. Available from: http://www.hearst.com/newsroom/q-a-with-mike-smith. Accessed July 28, 2015.
   Google Scholar
• Hearst Digital Media. Mobile. Available from: http://www.hearst.com/newsroom/mobile. Accessed July 28, 2015.
   Google Scholar
• Doctor K. The newsonomics of Hearst Magazines’ one million new customers. 2013. Available from: http://www.niemanlab.org/2013/06/the-newsonomics-of-hearst-magazines-one-million-new-customers. Accessed July 28, 2015.
   Google Scholar
• Bazilian E. Publishers talk tablet strategy at MPA Swipe 2.0: Flipboard, Hearst, New York mag show off new features. 2013. Available from: http://www.adweek.com/news/press/publishers-talk-tablet-strategy-mpa-swipe-20-148249. Accessed July 28, 2015.
   Google Scholar
• McGrath RG. Business models: a discovery driven approach. Long Range Plann. 2008;43(2–3):247–261.
   Web of Science ®Google Scholar
• Sosna M, Trevinyo-Rodríguez RN, Velamuri SR. Business model innovation through trial-and-error learning: the Naturhouse case. Long Range Plann. 2010;43(2):383–407.
   Web of Science ®Google Scholar
• Tebbey PW, Bergheiser J, Mattick RN. Brand momentum: the measure of great pharmaceutical brands. J Med Mark Device Diagn Pharm Mark. 2009;9(3):221–232.
   Google Scholar
• Robinson JC. Insurers’ strategies for managing the use and cost of biopharmaceuticals. Health Aff (Millwood). 2006;25(5):1205–1217.
   Web of Science ®Google Scholar
• Condé Nast International. Brand: Vogue. Available from: http://www.condenastinternational.com/brand/?b=vogue#vogue. Accessed July 28, 2015.
   Google Scholar
• Condé Nast. About us. Available from: http://www.condenast.com/about-us. Accessed July 28, 2015.
   Google Scholar
• Adams R. New business model in vogue at Condé Nast. 2011. Available from: http://www.wsj.com/articles/SB10001424052702303654804576347861638730194. Accessed July 28, 2015.
   Google Scholar
• Smith SD. Closing four magazines, Condé Nast reshaping in publishing’s new era. 2009. Available from: http://wwd.com/wwd-publications/wwd/2009-10-06-2108470. Accessed July 28, 2015.
   Google Scholar
• Condé Nast. Vogue: overview of opportunities. Available from: http://digital-assets.condenast.co.uk.s3.amazonaws.com/static/condenast/VOGUE%20Media%20Kit%2031032015.pdf. Accessed July 28, 2015.
   Google Scholar
• Condé Nast. Vogue Fashion’s Night Out. Available from: http://www.condenastinternational.com/initiatives/vogue-fashions-night-out. Accessed July 28, 2015.
   Google Scholar
• InPublishing. Condé Nast unveils digital plans. 2013. Available from: http://www.inpublishing.co.uk/news/articles/conde_nast_unveils_digital_plans_6658.aspx. Accessed July 28, 2015.
   Google Scholar
• Sharp PA. Meeting global challenges: discovery and innovation through convergence. Science. 2014;346(6216):1468–1471.
   Web of Science ®Google Scholar
• Chesbrough HW. The era of open innovation. Sloan Manage Rev. 2003;44(3):35–41.
   Google Scholar
• Von Hippel E. Democratizing innovation: the evolving phenomenon of user innovation. J Betriebswirtschaft. 2005;55(1):63–78.
   Google Scholar